Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1969 1
1970 1
1971 1
1976 1
1979 1
1981 1
1985 1
1987 1
1988 1
1990 3
1991 4
1992 4
1994 1
1995 1
1996 2
1997 1
1998 2
2000 3
2001 4
2002 3
2003 4
2004 1
2005 3
2006 5
2007 2
2008 4
2009 1
2010 1
2011 4
2012 4
2013 7
2014 3
2015 2
2016 4
2017 8
2018 3
2019 9
2020 4
2021 3
2022 5
2023 6
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

114 results

Results by year

Filters applied: . Clear all
Page 1
The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015.
Nicholson AG, Tsao MS, Beasley MB, Borczuk AC, Brambilla E, Cooper WA, Dacic S, Jain D, Kerr KM, Lantuejoul S, Noguchi M, Papotti M, Rekhtman N, Scagliotti G, van Schil P, Sholl L, Yatabe Y, Yoshida A, Travis WD. Nicholson AG, et al. J Thorac Oncol. 2022 Mar;17(3):362-387. doi: 10.1016/j.jtho.2021.11.003. Epub 2021 Nov 20. J Thorac Oncol. 2022. PMID: 34808341 Free article. Review.
The 2021 WHO Classification of Thoracic Tumours was published earlier this year, with classification of lung tumors being one of the chapters. The principles remain those of using morphology first, supported by immunohistochemistry, and then molecular techniques. ...Major …
The 2021 WHO Classification of Thoracic Tumours was published earlier this year, with classification of lung tumors being one of the …
Adenocarcinoma classification: patterns and prognosis.
Kuhn E, Morbini P, Cancellieri A, Damiani S, Cavazza A, Comin CE. Kuhn E, et al. Pathologica. 2018 Mar;110(1):5-11. Pathologica. 2018. PMID: 30259909 Free article. Review.
For invasive adenocarcinoma, the new classification has introduced histological subtyping according to the predominant pattern of growth of the neoplastic cells: lepidic (formerly non mucinous brochioloalveolar adenocarcinoma), acinar, papillary, micropapilla …
For invasive adenocarcinoma, the new classification has introduced histological subtyping according to the predominant pattern of gro …
International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma.
Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger KR, Yatabe Y, Beer DG, Powell CA, Riely GJ, Van Schil PE, Garg K, Austin JH, Asamura H, Rusch VW, Hirsch FR, Scagliotti G, Mitsudomi T, Huber RM, Ishikawa Y, Jett J, Sanchez-Cespedes M, Sculier JP, Takahashi T, Tsuboi M, Vansteenkiste J, Wistuba I, Yang PC, Aberle D, Brambilla C, Flieder D, Franklin W, Gazdar A, Gould M, Hasleton P, Henderson D, Johnson B, Johnson D, Kerr K, Kuriyama K, Lee JS, Miller VA, Petersen I, Roggli V, Rosell R, Saijo N, Thunnissen E, Tsao M, Yankelewitz D. Travis WD, et al. J Thorac Oncol. 2011 Feb;6(2):244-85. doi: 10.1097/JTO.0b013e318206a221. J Thorac Oncol. 2011. PMID: 21252716 Free PMC article. Review.
INTRODUCTION: Adenocarcinoma is the most common histologic type of lung cancer. To address advances in oncology, molecular biology, pathology, radiology, and surgery of lung adenocarcinoma, an international multidisciplinary classification was sponsore …
INTRODUCTION: Adenocarcinoma is the most common histologic type of lung cancer. To address advances in oncology, molecular bio …
RET fusions in solid tumors.
Li AY, McCusker MG, Russo A, Scilla KA, Gittens A, Arensmeyer K, Mehra R, Adamo V, Rolfo C. Li AY, et al. Cancer Treat Rev. 2019 Dec;81:101911. doi: 10.1016/j.ctrv.2019.101911. Epub 2019 Oct 30. Cancer Treat Rev. 2019. PMID: 31715421 Review.
When altered, RET mutations influence disease in a variety of organ systems from Hirschsprung's disease and multiple endocrine neoplasia 2 (MEN2) to papillary thyroid carcinoma (PTC) and non-small cell lung cancer (NSCLC). Changes in RET expression have been discove …
When altered, RET mutations influence disease in a variety of organ systems from Hirschsprung's disease and multiple endocrine neoplasia 2 ( …
The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
Chang S, Yim S, Park H. Chang S, et al. Exp Mol Med. 2019 Jun 20;51(6):1-17. doi: 10.1038/s12276-019-0230-6. Exp Mol Med. 2019. PMID: 31221981 Free PMC article. Review.
Table 1 Cancer driver genes involved in epigenetics Pathways involved in epigenetics Driver genes Tumor suppressor/oncogene prediction (by 20/20+(a)) Approved name Activity Cancer type(b) Other driver genes in this pathways Histone modification KDM6A tsg Lysine demethylase 6A, UT …
Table 1 Cancer driver genes involved in epigenetics Pathways involved in epigenetics Driver genes Tumor suppressor/oncogene prediction (by 2 …
Hepatoid adenocarcinoma of the lung: report of five cases and review of the literature.
Haninger DM, Kloecker GH, Bousamra Ii M, Nowacki MR, Slone SP. Haninger DM, et al. Mod Pathol. 2014 Apr;27(4):535-42. doi: 10.1038/modpathol.2013.170. Epub 2013 Sep 13. Mod Pathol. 2014. PMID: 24030743 Free article. Review.
The current diagnostic criteria for hepatoid adenocarcinoma of lung include typical acinar or papillary adenocarcinoma and a component resembling hepatocellular carcinoma and expressing alpha-fetoprotein (AFP). ...We studied morphologic features …
The current diagnostic criteria for hepatoid adenocarcinoma of lung include typical acinar or papillary adeno
The regulatory role of LncRNA HCG18 in various cancers.
Du Z, Wang B, Tan F, Wu Y, Chen J, Zhao F, Liu M, Zhou G, Yuan C. Du Z, et al. J Mol Med (Berl). 2023 Apr;101(4):351-360. doi: 10.1007/s00109-023-02297-5. Epub 2023 Mar 6. J Mol Med (Berl). 2023. PMID: 36872315 Review.
As outlined in this review, LncRNA HCG18 has been reported to be dysregulated in various cancers development and appears to be activated in a variety of tumors, including clear cell renal cell carcinoma (ccRCC), colorectal cancer (CRC), gastric cancer (GC), hepatocellular carcino …
As outlined in this review, LncRNA HCG18 has been reported to be dysregulated in various cancers development and appears to be activated in …
Napsin A expression in lung and kidney neoplasia: a review and update.
Ordóñez NG. Ordóñez NG. Adv Anat Pathol. 2012 Jan;19(1):66-73. doi: 10.1097/PAP.0b013e31823e472e. Adv Anat Pathol. 2012. PMID: 22156835 Review.
Napsin A is an aspartic protease present in the epithelial cells of the lung and kidney. Recent studies have shown that, in lung tumors, napsin A expression is restricted to lung adenocarcinomas, whereas among renal tumors, it is frequently expressed in renal …
Napsin A is an aspartic protease present in the epithelial cells of the lung and kidney. Recent studies have shown that, in lung
Classification of different patterns of pulmonary adenocarcinomas.
Truini A, Santos Pereira P, Cavazza A, Spagnolo P, Nosseir S, Longo L, Jukna A, Lococo F, Vincenzi G, Bogina G, Tiseo M, Rossi G. Truini A, et al. Expert Rev Respir Med. 2015 Oct;9(5):571-86. doi: 10.1586/17476348.2015.1083428. Epub 2015 Aug 27. Expert Rev Respir Med. 2015. PMID: 26313326 Review.
The new 2015 WHO classification provided the basis for a multidisciplinary approach emphasizing the close correlation among clinical, radiologic and molecular characteristics and histopathologic pattern of lung adenocarcinoma. The terms 'bronchioloalveolar carcinoma …
The new 2015 WHO classification provided the basis for a multidisciplinary approach emphasizing the close correlation among clinical, radiol …
Metastatic lung carcinoma in thyroid aspirates: A case series and literature review illustrating diagnostic challenges.
Ng JKM, Li JJX. Ng JKM, et al. Cytopathology. 2022 Nov;33(6):696-706. doi: 10.1111/cyt.13164. Epub 2022 Jul 26. Cytopathology. 2022. PMID: 35808980 Review.
Metastatic adenocarcinoma of the lung is an under-recognised mimicker which overlaps cytomorphologically and immunocytochemically with PTC. ...CONCLUSION: Metastatic adenocarcinoma of lung and PTC share significant cytomorphological and immunocy …
Metastatic adenocarcinoma of the lung is an under-recognised mimicker which overlaps cytomorphologically and immunocytochemica …
114 results